Full-Time

Clinical Scientist

R&D, Clinical Affairs

Confirmed live in the last 24 hours

Hologic

Hologic

5,001-10,000 employees

Develops medical devices and diagnostic products

Compensation Overview

$110.9k - $175.1k/yr

+ Bonus

Senior

Marlborough, MA, USA

In Person

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
SAS
R
Stata
Google Cloud Platform
Requirements
  • Advanced degree (Master’s or PhD) in a relevant clinical or scientific discipline, with 6+ years of experience in clinical research or R&D.
  • Expertise in clinical study design, evidence generation, and regulatory compliance (e.g., FDA, ISO, GCP).
  • Strong knowledge of biostatistics and proficiency in tools like STATA, SAS, or R.
  • Excellent communication and collaboration skills, with the ability to work effectively in a matrixed environment.
  • Proven ability to think strategically, manage multiple projects, and deliver results in a dynamic setting.
Responsibilities
  • Lead clinical research activities to establish safety and efficacy performance criteria for medical devices.
  • Design, initiate, and manage internal and external clinical studies, ensuring alignment with regulatory and business objectives.
  • Conduct systematic literature reviews and critical appraisals of clinical evidence to support product positioning and market expansion.
  • Collaborate with R&D, Regulatory Affairs, and Marketing to integrate clinical strategies into product development and commercialization plans.
  • Build and cultivate relationships with external experts, academic institutions, and research organizations.
  • Monitor competitive landscapes and provide insights into emerging trends and ongoing clinical studies.

Hologic focuses on improving health through early detection and treatment solutions in the medical technology field. The company develops and sells medical devices and diagnostic products, particularly in areas like breast and skeletal health, GYN surgical products, and medical aesthetics. Hologic's products work by providing reliable diagnostic tools that help healthcare providers identify diseases early and treat them effectively. Unlike many competitors, Hologic has a strong emphasis on innovation and quality, which has established it as a trusted partner in the healthcare sector. The company's goal is to enhance health and well-being globally by offering advanced solutions that address critical health issues.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Santa Clara, null

Founded

1985

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven diagnostic tools enhance early detection and operational efficiency in healthcare.
  • The global AI medical imaging market is projected to grow significantly by 2028.
  • Increasing breast cancer prevalence boosts demand for Hologic's screening and diagnostic solutions.

What critics are saying

  • Potential private equity takeover could lead to strategic shifts misaligned with current goals.
  • Closure of Connecticut plant and layoffs may impact production capacity and morale.
  • Increased competition in AI mammography technology pressures Hologic to innovate rapidly.

What makes Hologic unique

  • Hologic specializes in breast and skeletal health, diagnostics, and GYN surgical products.
  • The company is a leader in AI-driven mammography technology for early cancer detection.
  • Hologic's global presence spans key markets like the USA, China, and Europe.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Performance Bonus

Company News

Business Insider
May 27th, 2025
TPG, Blackstone $16B Offer for Hologic

TPG and Blackstone have proposed a deal to take Hologic private, valuing the company at $16.3-$16.7 billion, including debt, according to the Financial Times. Although Hologic recently rejected the non-binding offer, there remains a possibility for renewed discussions. The news also mentions Hologic's trading halt due to volatility, and recent price target adjustments by Stephens and Morgan Stanley.

The ICE Community
Apr 25th, 2025
New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI

Hologic Inc. will have a strong presence at the Society of Breast Imaging (SBI) Annual Symposium in Colorado Springs, Colorado, including the presentation of pivotal new research conducted by a top-tier healthcare facility focused on the company's AI-driven mammography technology.

Business Wire
Feb 25th, 2025
Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference

Hologic to webcast presentation at the Raymond James 46th Annual Institutional Investors Conference.

ETF Daily News
Jan 11th, 2025
Diversified Trust Co Makes New Investment in Hologic, Inc. (NASDAQ:HOLX)

Diversified Trust Co makes new investment in Hologic, Inc. (NASDAQ:HOLX).

WB Journal
Dec 23rd, 2024
Results: How did WBJ do with 2024's bold predictions?

The industry is still right-sizing itself after its rapid expansion in the wake of COVID-19, and a few companies laid off dozens of employees: Marlborough-based Sumitomo Pharma America laid off 53, and Marlborough-based Hologic is closing a plant in Connecticut, resulting in 86 layoffs.